Overview
Lobbying Costs
1,250,000€ - 1,499,999€
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
2 Fte (5)
Lobbyists with EP accreditation
3
High-level Commission meetings
17
Lobbying Costs over the years
-
Info
Pfizer Inc. (PFE)
EU Transparency Register
4263301811-33 First registered on 18 Dec 2008
Goals / Remit
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.
Main EU files targeted
Revision of general EU pharmaceutical legislation, digital health e.g. European Health Data Space, AI Regulation, gene therapy, pharmaceutical strategy, Paediatric & Orphan Review, Vaccination policy, HTA Regulation, Pharmaceuticals in the Environment, IHI and research programs, EU trade negotiations, corporate tax, Covid-19 vaccines & therapeutics procurement, HERA & bio-preparedness.
Address
Head Office
East 42nd Street, 235
New York NY 10017
UNITED STATESEU Office
Boulevard de la Plaine, 17
Brussels 1050
BELGIUMWebsite
-
People
Total lobbyists declared
5
Employment time Lobbyists 50% 3 25% 2 Lobbyists (Full time equivalent)
2
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
3 accreditations were / are live (in bold) for the selected state of 01 Apr 2023
Name Start date End Date Mr Victor DE DECKER 18 Oct 2022 21 Jan 2023 Mr CHARLES FAID 09 Sep 2022 07 Sep 2023 Mr Riccardo ROVERA 01 Jul 2022 30 Jun 2023 Mr ANDREA CHIARELLO 25 Jun 2022 23 Jun 2023 Ms Eva GRUT AANDAHL 25 Mar 2022 24 Mar 2023 Mr Yordan Aleksandrov 24 Mar 2022 23 Mar 2023 Mr Franjo CAIC 07 Jul 2021 21 Sep 2021 Mr ANDREA CHIARELLO 06 Jul 2021 25 Jun 2022 Ms HEIKE GALBRAITH 06 Mar 2021 15 Jan 2022 Ms Eva GRUT AANDAHL 06 Mar 2021 05 Mar 2022 Mr ANDREA CHIARELLO 14 Aug 2020 06 Jul 2021 Mr Franjo CAIC 06 Aug 2020 07 Jul 2021 Ms EVA GRUT AANDAHL 12 Feb 2020 01 Mar 2021 Mr CHARLES FAID 12 Feb 2020 01 Mar 2021 Ms HEIKE GALBRAITH 12 Feb 2020 01 Mar 2021 Mr Matthew Thomas CLAY 14 Dec 2019 12 Dec 2020 Mr ANDREA CHIARELLO 06 Sep 2019 14 Aug 2020 Mr Franjo CAIC 22 Aug 2019 06 Aug 2020 Ms EVA GRUT AANDAHL 06 Feb 2019 12 Feb 2020 Mr CHARLES FAID 06 Feb 2019 12 Feb 2020 Ms HEIKE GALBRAITH 06 Feb 2019 12 Feb 2020 Mr Matthew Thomas CLAY 12 Dec 2018 12 Dec 2019 Mr ANDREA CHIARELLO 26 Sep 2018 06 Sep 2019 Ms EVA GRUT AANDAHL 03 Feb 2018 02 Feb 2019 Mr CHARLES FAID 03 Feb 2018 02 Feb 2019 Ms HEIKE GALBRAITH 03 Feb 2018 02 Feb 2019 Mr Matthew Thomas CLAY 09 Jan 2018 12 Dec 2018 Mr ANDREA CHIARELLO 01 Sep 2017 01 Sep 2018 Ms EVA GRUT AANDAHL 21 Feb 2017 03 Feb 2018 Mr CHARLES FAID 21 Feb 2017 03 Feb 2018 Ms HEIKE GALBRAITH 21 Feb 2017 03 Feb 2018 Mr Matthew Thomas CLAY 23 Jan 2017 09 Jan 2018 Mr ANDREA CHIARELLO 30 Sep 2016 01 Sep 2017 Ms EVA GRUT AANDAHL 10 Mar 2016 22 Feb 2017 Mr CHARLES FAID 10 Mar 2016 22 Feb 2017 Ms HEIKE GALBRAITH 10 Mar 2016 22 Feb 2017 Mr Matthew Thomas CLAY 15 Jan 2016 14 Jan 2017 Mr ANDREA CHIARELLO 28 Aug 2015 31 Aug 2016 Ms EVA GRUT AANDAHL 19 Feb 2015 17 Feb 2016 Mr CHARLES FAID 25 Feb 2015 18 Feb 2016 Ms HEIKE GALBRAITH 25 Feb 2015 23 Feb 2016 Mr Matthew Thomas CLAY 09 Jan 2015 07 Jan 2016 Mr Matthew Thomas CLAY 16 Jan 2014 09 Jan 2015 Ms EVA GRUT AANDAHL 14 Feb 2013 13 Feb 2014 Mr Matthew Thomas CLAY 17 Jan 2013 06 Dec 2013 Mr Matthew Thomas CLAY 20 Dec 2011 08 Feb 2013 Complementary Information
3 colleagues are full-time engaged in the Brussels office and spend approx. 50% of their time on EU affairs. Moreover, 2 other colleagues engaged in Brussels spend about 25%. Finally, a number of colleagues (most not based in Brussels) spend between 0-10%< of their time, of which one has applied for a European Parliament access badge (25 October 2022).
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
In 2022 Pfizer was a member of: EFPIA, Vaccines Europe, EuropaBio, Amcham EU, BusinessEurope, TABC & AECA.
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
1,250,000€ - 1,499,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount zn consulting 100,000€ - 199,999€ fleishman-hillard 100,000€ - 199,999€ hanbury strategy 10,000€ - 24,999€ fti consulting 10,000€ - 24,999€ rpp group 50,000€ - 99,999€ Intermediaries for current year
Name rpp group zn consulting fleishman-hillard fti consulting Closed year Costs
1,250,000€ - 1,499,999€
Other financial info
The amount declared in answer (c) includes: relevant percentage of trade associations' work, consultants as declared, percentage of colleagues' fully loaded salary and office expenses.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Other activities
Pharmaceuticals, healthcare, innovation and research, intellectual property, business competitiveness, trade, environment
Meetings
Meetings
17 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.
-
Date 09 Sep 2022 Location Thessaloniki Subject Pharma Strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Commission - Margaritis Schinas (Vice-President)
-
Date 26 Nov 2021 Location Videoconference Subject Meeting with CEO of Pfizer Cabinet Cabinet of President Ursula von der Leyen Portfolio President Commission - Ursula von der Leyen (President)
-
Date 26 Oct 2021 Location Brussels Subject Pharmaceutical sector – trade related issues Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Commission - Caroline Boeshertz (Cabinet member)
- Kevin Keary (Cabinet member)
- Elina Melngaile (Cabinet member)
Other Lobbyists -
Date 18 Oct 2021 Location Phone call Subject Call with Pfizer’s Regional President for Vaccines, Mr. Sinan Atlig, to discuss the implementation of COVID-19 vaccines Advance Purchase Agreement Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Commission - Giorgios Rossides (Cabinet member)
- Roberto Reig Rodrigo (Cabinet member)
-
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Commission - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
Other Lobbyists - SANOFI
- Medichem, S.A.
- Novo Nordisk A/S
- Phamaceutical Group of the European Union
- European Healthcare Distribution Association
- MEDICINES FOR EUROPE
- European Federation of Pharmaceutical Industries and Associations
- Leuphana Universität Lüneburg
- Teva Pharmaceuticals Europe BV
- Bureau Européen des Unions de Consommateurs
- The European Association of Hospital Pharmacists
- Fresenius Kabi Deutschland GmbH
- European Chemical Industry Council
- European Patients' Forum (EPF)
-
Date 07 May 2021 Location Puurs, Belgium Subject Site visit and assessment of production capacity and supply chain Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Commission - Maurits-Jan Prinz (Cabinet member)
-
Date 10 Apr 2021 Location Videocall Subject Vaccine production and deliveries Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Commission - Thierry Breton (Commissioner)
Other Lobbyists -
Date 07 Apr 2021 Location Brussels Subject Vaccine delivery schedule for Q2 2021 Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Commission - Maurits-Jan Prinz (Cabinet member)
-
Date 21 Feb 2021 Location Puurs, Belgium Subject COVID-19 vaccines production Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Commission - Thierry Breton (Commissioner)
-
Date 31 Jan 2021 Location Videoconference Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements Cabinet Cabinet of President Ursula von der Leyen Portfolio President Commission - Ursula von der Leyen (President)
Other Lobbyists -
Date 27 Nov 2018 Location Brussels Subject EU-US relations, trade aspects of Brexit Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Commission - Nele Eichhorn (Cabinet member)
-
Date 29 Nov 2017 Location Brussels Subject Pharmaceutical incentives, antimicrobial resistance Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Commission - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists -
Date 21 Nov 2017 Location Brussels Subject Internal Market's industrial property legal framework relating to supplementary protection certificates (SPC) and patent research exemptions; innovation in the pharmaceutical industry Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Commission - Jyrki Katainen (Vice-President)
Other Lobbyists -
Date 01 Sep 2017 Location Cernobbio Subject Exchange of views on the Italian and euro zone economies and priorities for reform Cabinet Cabinet of Commissioner Pierre Moscovici Portfolio Economic and Financial Affairs, Taxation and Customs Commission - Simon O'Connor (Cabinet member)
- Pierre Moscovici (Commissioner)
Other Lobbyists -
Date 02 Mar 2015 Location Brussels Subject Access to innovative medicine Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Commission - Annika Nowak (Cabinet member)
-
Date 27 Jan 2015 Location Brussels Belgium Subject Introductory meeting Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Commission - Rolf Carsten Bermig (Cabinet member)